formaldehyde has been researched along with dacarbazine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hill, DL | 1 |
| Enomoto, T; Ishikawa, E; Matsumura, A; Morishita, Y; Nakai, K; Ohno, T; Sakamoto, N; Sato, M; Satomi, K; Takano, S; Tsuboi, K; Yamamoto, T | 1 |
3 other study(ies) available for formaldehyde and dacarbazine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Microsomal metabolism of triazenylimidazoles.
Topics: Animals; Antineoplastic Agents; Dacarbazine; Female; Formaldehyde; Hydrogen-Ion Concentration; Imidazoles; In Vitro Techniques; Kinetics; Mice; Mice, Inbred DBA; Microsomes, Liver; NADP; Nitrogen Mustard Compounds; Sarcoma 180; Triazenes | 1975 |
Pathological changes after autologous formalin-fixed tumor vaccine therapy combined with temozolomide for glioblastoma - three case reports - .
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cancer Vaccines; Combined Modality Therapy; Dacarbazine; Female; Formaldehyde; Frontal Lobe; Glioblastoma; Humans; Male; Middle Aged; Temozolomide; Treatment Outcome | 2011 |